LENZ Therapeutics, Inc.LENZNASDAQ
Loading
Operating Income Growth Under PressureDecelerating
Percentile Rank55
Studio
Year-over-Year Change

Year-over-year operating income growth rate

Percentile
P55
Within normal range
vs 3Y Ago
-5.2x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
PeriodValue
Q3 2025-12.04%
Q2 20250.44%
Q1 2025-11.21%
Q4 2024-17.61%
Q3 20249.80%
Q2 202410.79%
Q1 202435.62%
Q4 2023-25.79%
Q3 2023-32.80%
Q2 2023-18.57%
Q1 2023-38.23%
Q4 202265.10%
Q3 20222.32%
Q2 2022-3.15%
Q1 2022-37.05%
Q4 2021-29.71%
Q3 202116.72%
Q2 2021-87.16%
Q1 2021-12.56%
Q4 2020-121.12%
Q3 2020-191.33%
Q2 2020-967.77%
Q1 20200.00%